Mwandishi:
Mhariri:
Imeboreshwa:
ULY CLINIC
ULY CLINIC
20 Februari 2026, 04:36:31
Surgery and Procedures in the Context of COVID-19
Comprehensive Peri-operative Infection Prevention and Resource-Stewardship Guideline
(Applicable during outbreaks of infection caused by COVID-19 and transmission of SARS‑CoV‑2)
1. PURPOSE AND AIMS
The purpose of this guideline is to provide a structured, evidence-based framework for delivering safe surgical and anesthetic care during a respiratory viral pandemic.
Primary Objectives
Protect the patient
Prevent peri-operative viral exposure
Reduce postoperative pulmonary complications
Ensure appropriate surgical prioritization
Protect healthcare workers
Reduce aerosol exposure
Standardize PPE utilization
Prevent intra-hospital outbreaks
Preserve critical resources
Ventilators
ICU beds
Oxygen supply
Personal Protective Equipment (PPE)
Workforce availability
Maintain essential surgical services
Save life
Preserve organ function
Prevent irreversible disease progression
2. SURGICAL PRIORITIZATION FRAMEWORK
During a pandemic surge, surgery is not stopped — it is stratified.
A. Emergency (Operate Immediately)
Conditions where delay results in death or permanent disability:
Category | Examples |
Life-threatening | Major trauma, ruptured ectopic pregnancy, perforated viscus |
Limb-threatening | Compartment syndrome, acute ischemia |
Airway-threatening | Obstructed airway |
Obstetric | Emergency LSCS |
B. Urgent / Time-Sensitive (Operate within days–weeks)
Category | Examples |
Oncologic | Curative cancer resection without chemo/radiation alternative |
Progressive disease | Bowel obstruction without strangulation |
Severe infection | Abscess requiring drainage |
C. Elective (Delay Until After Peak)
Examples:
Hernia repair
Cosmetic surgery
Non-urgent endoscopy
Joint replacement
Benign masses
3. INFORMED CONSENT DURING PANDEMIC
Consent must specifically include:
Risk of hospital-acquired viral infection
Increased pulmonary complications
Possible postoperative isolation
Visitor restrictions
ICU bed limitations
Possibility of treatment modification due to resource scarcity
Consent may be obtained from:
Patient
Legal surrogate
Emergency implied consent (life-saving situations)
4. OPERATING THEATRE DESIGNATION
Dedicated COVID Operating Theatre
All confirmed positive patients should be managed in a separate designated operating theatre:
Requirements
Separate entry/exit pathway
Negative pressure preferred
Dedicated anesthesia machine
Dedicated surgical instruments
Dedicated donning/doffing area
5. IN-THEATRE PRACTICE PROTOCOL
Staffing
Minimum personnel only
No observers or students
Fixed surgical teams if possible
Ventilation Control
Positive pressure OFF during aerosol-generating procedures
Resume after ≥20 minutes air exchange
Negative pressure preferred
Airway Management (Highest Risk Phase)
Only most experienced anesthesiologist performs:
Step | Principle |
Intubation | Rapid sequence induction |
Extubation | Smooth, anti-cough strategy |
Equipment | Video laryngoscope preferred |
Staff presence | Absolute minimum |
Energy Devices
Use smoke evacuation for:
Diathermy
Laser
Ultrasonic devices
Reason: Viral particles may aerosolize in surgical smoke.
Post-operative Ventilation
Avoid elective postoperative ventilation where possible to preserve ICU resources.
6. PERIOPERATIVE SCREENING AND TESTING
Clinical Screening (All Patients)
Check for:
Fever
Cough
Dyspnea
Exposure history (last 7–14 days)
Laboratory Testing
PCR test within 72 hours pre-procedure
Self-quarantine after testing until surgery
Emergency cases: treat as positive
7. PATIENT RISK CLASSIFICATION
Category | Meaning |
Asymptomatic | No symptoms |
Asymptomatic + Exposure | Contact history |
Symptomatic | Suspected infection |
Confirmed | Laboratory positive |
Pre-symptomatic | Infectious before symptoms |
8. PERSONAL PROTECTIVE EQUIPMENT (PPE)
Standard COVID PPE
N95 respirator
Eye protection (goggles/face shield)
Gown
Double gloves
Augmented COVID PPE
PAPR/CAPR respirator
Full gown
Double gloves
Eye protection
9. HIGH-RISK VS ULTRA-HIGH-RISK PROCEDURES
High-Risk Procedures
Aerosol likely but controlled:
Thoracic surgery with lung isolation
Bronchoscopy
GI endoscopy
Cardioversion
Cesarean section with GA risk
Ultra-High-Risk Procedures
Direct airway aerosolization:
Tracheostomy
ENT airway surgery
Nasopharyngeal procedures
Rigid bronchoscopy
Oropharyngeal surgery
Require Augmented PPE
10. OPERATIVE MANAGEMENT SCENARIOS
WHEN TESTING NOT AVAILABLE
D1 — Low-Risk Urgent
N95 + shield
Minimal staff
15-min entry delay after intubation
15-min exit delay after extubation
D2 — High-Risk Emergency
Full PPE for all staff
Augmented PPE for ultra-risk
Continuous PPE use entire procedure
D3 — Symptomatic or Exposure
Assume positive
COVID ward post-op
Leave intubated if needed
WHEN TESTING AVAILABLE
F1 — COVID Negative
Standard OR protocol
F2 — COVID Positive Asymptomatic
Full PPE
Delayed entry/exit
F3 — Symptomatic Outpatient Positive
Full PPE
Minimal staff
F4 — Symptomatic Inpatient Positive
Transfer to COVID unit post-op
11. POSTOPERATIVE MANAGEMENT
Patient Pathway
Status | Destination |
Negative | Regular ward |
Suspected | Isolation |
Positive | COVID unit/ICU |
Staff Decontamination
Doff PPE in designated zone
Hand hygiene after each removal step
Shower recommended after high-risk exposure
Theatre Decontamination
Chlorine disinfectant surfaces
Air exchange ≥20 minutes
Terminal cleaning
Waste treated as infectious
12. CORE PRINCIPLE
During a pandemic every surgical patient must be assumed infectious until proven otherwise.
This strategy protects:
Patients
Staff
Hospital systems
Community transmission chains
References
Ministry of Health, Community Development, Gender, Elderly and Children (United Republic of Tanzania). Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. March 2021.
World Health Organization. Clinical management of severe acute respiratory infection when COVID-19 is suspected. WHO; 2020.
World Health Organization. Infection prevention and control during health care when coronavirus disease (COVID-19) is suspected or confirmed. WHO Interim Guidance; 2020.
World Health Organization. Coronavirus disease (COVID-19) Situation Report – 46. WHO; 2020.
Del Rio C, Malani PN. 2019 Novel Coronavirus—Important Information for Clinicians. JAMA. 2020;323(11):1039-1040.
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382:1708-1720.
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of COVID-19 pneumonia in Wuhan, China. Lancet. 2020;395(10223):507-513.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China. Lancet. 2020;395:1054-1062.
Zhao D, Yao F, Wang L, Zheng L, Gao Y, Ye J, et al. A comparative study on the clinical features of COVID-19 pneumonia to other pneumonias. Clin Infect Dis. 2020.
Yoon SH, Lee KH, Kim JY, Lee YK, Ko H, Kim KH, et al. Chest Radiographic and CT Findings of COVID-19: Analysis of Nine Patients Treated in Korea. Korean J Radiol. 2020;21(4):494-500.
Peng QY, Wang XT, Zhang LN. Findings of lung ultrasonography of COVID-19 pneumonia. Intensive Care Med. 2020.
van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al. Aerosol and Surface Stability of SARS-CoV-2 compared with SARS-CoV-1. N Engl J Med. 2020;382:1564-1567.
Alhazzani W, Møller MH, Arabi YM, Loeb M, Gong MN, Fan E, et al. Surviving Sepsis Campaign Guidelines on the Management of Critically Ill Adults with COVID-19. Crit Care Med. 2020.
Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-810.
Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, et al. Acute Respiratory Distress Syndrome: The Berlin Definition. JAMA. 2012;307(23):2526-2533.
Australian and New Zealand Intensive Care Society (ANZICS). COVID-19 Guidelines. Melbourne; 2020.
World Confederation for Physical Therapy. Physiotherapy management for COVID-19 (Version 1.0). 2020.
Queensland Health Clinical Excellence Division. COVID-19 Action Plan: Statewide General Medicine Clinical Network. 2020.
Imeandikwa:
25 Machi 2021, 06:10:45
